TY - JOUR
T1 - Expansion of the GRIA2 phenotypic representation
T2 - a novel de novo loss of function mutation in a case with childhood onset schizophrenia
AU - Alkelai, Anna
AU - Shohat, Shahar
AU - Greenbaum, Lior
AU - Schechter, Tanya
AU - Draiman, Benjamin
AU - Chitrit-Raveh, Eti
AU - Rienstein, Shlomit
AU - Dagaonkar, Neha
AU - Hughes, Daniel
AU - Aggarwal, Vimla S.
AU - Heinzen, Erin L.
AU - Shifman, Sagiv
AU - Goldstein, David B.
AU - Kohn, Yoav
N1 - Publisher Copyright:
© 2020, The Author(s), under exclusive licence to The Japan Society of Human Genetics.
PY - 2021/3
Y1 - 2021/3
N2 - Childhood-onset schizophrenia (COS) is a rare form of schizophrenia with an onset before 13 years of age. There is rising evidence that genetic factors play a major role in COS etiology, yet, only a few single gene mutations have been discovered. Here we present a diagnostic whole-exome sequencing (WES) in an Israeli Jewish female with COS and additional neuropsychiatric conditions such as obsessive-compulsive disorder (OCD), anxiety, and aggressive behavior. Variant analysis revealed a de novo novel stop gained variant in GRIA2 gene (NM_000826.4: c.1522 G > T (p.Glu508Ter)). GRIA2 encodes for a subunit of the AMPA sensitive glutamate receptor (GluA2) that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. GluA2 subunit mutations are known to cause variable neurodevelopmental phenotypes including intellectual disability, autism spectrum disorder, epilepsy, and OCD. Our findings support the potential diagnostic role of WES in COS, identify GRIA2 as possible cause to a broad psychiatric phenotype that includes COS as a major manifestation and expand the previously reported GRIA2 loss of function phenotypes.
AB - Childhood-onset schizophrenia (COS) is a rare form of schizophrenia with an onset before 13 years of age. There is rising evidence that genetic factors play a major role in COS etiology, yet, only a few single gene mutations have been discovered. Here we present a diagnostic whole-exome sequencing (WES) in an Israeli Jewish female with COS and additional neuropsychiatric conditions such as obsessive-compulsive disorder (OCD), anxiety, and aggressive behavior. Variant analysis revealed a de novo novel stop gained variant in GRIA2 gene (NM_000826.4: c.1522 G > T (p.Glu508Ter)). GRIA2 encodes for a subunit of the AMPA sensitive glutamate receptor (GluA2) that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. GluA2 subunit mutations are known to cause variable neurodevelopmental phenotypes including intellectual disability, autism spectrum disorder, epilepsy, and OCD. Our findings support the potential diagnostic role of WES in COS, identify GRIA2 as possible cause to a broad psychiatric phenotype that includes COS as a major manifestation and expand the previously reported GRIA2 loss of function phenotypes.
UR - http://www.scopus.com/inward/record.url?scp=85091002350&partnerID=8YFLogxK
U2 - 10.1038/s10038-020-00846-1
DO - 10.1038/s10038-020-00846-1
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 32948840
AN - SCOPUS:85091002350
SN - 1434-5161
VL - 66
SP - 339
EP - 343
JO - Journal of Human Genetics
JF - Journal of Human Genetics
IS - 3
ER -